Radiation Oncology 2018 Online Review

Now with CME credit!

Available as Video or Audio in 3 and 12 months options. Starting as low as 295.00.

Sample Video If you have purchased the online review and are seeing this sample video you need to login and return to this page.

Release Date: May 16, 2018
Expiration Date: May 15, 2021
Estimated Time to Complete: 35 hours

Clear
SKU: OLRROC201805 Category: Online ReviewCategory: Radiation Oncology

Description

The Osler Institute utilized state of the art equipment to record our Live May 2018 comprehensive Radiation Oncology Review Course and bring it to you! These video files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection. This review provides senior trainees and/or clinicians in practice a comprehensive update of clinical knowledge and helps prepare them for their Radiation Oncology exams (initial certification and MOC). Emphasis is on evidence-based medicine and board-relevant standards of care as well as new concepts, treatments, and imaging approaches. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and chemotherapy adjuvant treatments, follow-up treatment and evaluation, patterns of failure, and normal tissue effects including complications; all of these areas were addressed in the recorded course. The review also covers the basic principles of radiobiology and physics that are relevant to clinical practice. Included with each Online review is an electronic downloadable copy of the syllabus that corresponds to the Video/Audio lectures.

Learn More

Additional information

Subscription Term

Video Three Months $675.00, Video One Year $895.00, Audio Three Months $295.00, Audio One Year $475.00

CME

Accreditation Statement

The Osler Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Osler Institute designates this Enduring Material activity for a maximum of 35 AMA PRA Category 1 Credit(s)TM. Each physician should claim only the credit commensurate with the extent of their participation in the activity.

Required Physician Participation

Review the audio/video lectures at your own pace. To claim CME credit, Learners must successfully complete a self-assessment post-test (score of 75% or greater is required more than one attempt is allowed and feedback is provided) and activity evaluation to test knowledge gained and its application to your practice.

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly-provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations.

The following faculty/planners/reviewers disclosed a relevant financial relationship(s).

Michael Chuong, MD – Speaker for Accuray, Inc.
Chirag Shah, MD – Consultant for ImpediMed, In

The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.

Parul Barry, MD
Dukagjin Blakaj, MD, PhD
Steven Lin, MD, PhD
Victor Mangona, MD
Ravi Shridhar, MD, PhD†*
Todd Swanson, MD, PhD†
Christina Pearison†
Joseph Selliken, MD†
Michael Stewart†Sally
Schuette, PhD†

Copies of the Faculty Disclosure Forms are available upon request.
† Program Planning Committee
* Reviewer if Applicable

Faculty and Topics

Parul Barry, MD
Assistant Professor of Radiation Oncology, Rush University Medical Center

Endometrial Cancer, Cervical Cancer, Vulvar Cancer

Dukagjin Blakaj, MD, Ph.D.
Assistant Professor of Radiation Oncology, Ohio State University

Head and Neck Cancer I – III

Michael Chuong, MD
Practicing Radiation Oncologist, University of South Florida

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma and Solitary Plasmacytoma

Steven Lin, MD, Ph.D.
Associate Professor of Radiation Oncology, MD Anderson Cancer Center

Early Stage NSCLC, Locally Advanced NSCLC, Small Cell Lung Cancer, Rare Mediastinal Tumors

Victor Mangona, MD
Practicing Radiation Oncologist, Texas Center for Proton Therapy, Irvine, TX

Pediatric Brain Tumors, Brain Stem Glioma, Medulloblastoma, Intracranial Germ Cell Tumors, Ependymoma, Pediatric Gliomas, Pediatric CNS Questions, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Ewing’s Sarcoma, Pediatric Solid Questions

Chirag Shah, MD
Associate Staff Director of Clinical Research, Cleveland Clinic Foundation

Early Stage Breast Cancer, Locally Advanced Breast Cancer, Carcinoma-in-situ and Misc (DCIS)

Ravi Shridhar, MD, PhD†
Associate Professor of Radiation Oncology, University of South Florida

Esophageal Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Liver Cancer, Pancreatic Ampullary Cancer, Bile Duct Cancer

Todd Swanson, MD, PhD†
Assistant Professor of Radiation Oncology, University of Texas, Galveston

CNS Overview, Primary CNS Malignancies, CNS Metastasis of Brain, CNS Metastasis Spine, Benign disorders of CNS, Palliative Care, Bladder, Penile, Prostate Cancer I, Prostate Cancer II

†Course Planning Committee

Objectives

At the conclusion of this course each participant should be able to perform the following tasks for all cancers of the eleven ABR defined component areas:

Describe the anatomy, epidemiology/etiologic agents, and natural history
Explain the pathology and use of tumor markers

Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)

Summarize potential treatment modalities including optimum beam and radiation sources, volume and dose calculations, as well as fractionation

Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects

Discuss the use of multimodality therapies including sequence, interactions, and specific agents

Describe brachytherapy applications and issues for all disease sites
Outline the use of palliative care for brain, hepatic and skeletal lesions, plus various obstructive scenarios

Implement a basic program of ethics, patient safety and quality assurance in clinical practice

How-To